Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Mitotane is an inhibitor of steroidogenesis.1 It decreases secretion of cortisol (Item No. 20739) and 17-hydroxy progesterone (Item No. 33154) from H295R adrenocortical carcinoma cells when used at a concentration of 50 µM. Mitotane also inhibits mitochondrial complex IV, also known as cytochrome c oxidase, activity in H295R cells (IC50 = 58 µM). It inhibits steroid production induced by adrenocorticotropic hormone (ACTH) and is cytotoxic to zona fasciculata and zona reticularis, but not zona glomerulosa, adrenal cortex cells in dogs when administered at a dose of 60 mg/kg.2 Formulations containing mitotane have been used in the treatment of adrenocortical carcinoma.
WARNING This product is not for human or veterinary use.
1. Mitotane alters mitochondrial respiratory chain activity by inducing cytochrome c oxidase defect in human adrenocortical cells. Endocr. Relat. Cancer 20(3), 371-381 (2013).
2. The effect of isomers of DDD on the ACTH-